Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-03-07Clinical Trial Update: Cognitive Remediation in Early Phase Psychosis [NA]
An update on a cognitive remediation clinical trial in early-phase psychosis sponsored by Oslo University Hospital; the study covers schizop…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Artemisinin to Reduce The Symptoms of Schizophrenia [NA]
An update on a completed clinical trial evaluating artemisinin for reducing symptoms in schizophrenia and schizoaffective disorder; results …
-
CLINICAL_TRIALS research · 2012-02-14Clinical Trial Update: An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia
A completed epidemiological study update evaluating psychosocial remission and community integration in individuals with schizophrenia (and …
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Vitamin D Supplementation in Psychiatric Illnesses [NA]
A completed University of Massachusetts Worcester trial evaluated vitamin D supplementation in people with obesity and vitamin D deficiency …
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial evaluating the efficacy and safety of two atypical antipsychotics versus placebo in acute exacerbations of schizophrenia or sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Open-label Phase 3 study evaluating intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder; results were …
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness [Phase 3]
Phase 3 trial assessing the impact of genetic counseling for female first-degree relatives of individuals with schizophrenia, bipolar disord…
-
CLINICAL_TRIALS research · 2011-11-01Clinical Trial Update: Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression
An observational study sponsored by AstraZeneca that completed and examined bipolar disorder symptoms in patients with schizophrenia, schizo…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia [Phase 3]
This document reports the results of a long-term safety Phase 3 study of lurasidone in clinically stable schizophrenia and schizoaffective d…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia (also including schizoaf…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder
This clinical trial update describes a specialized clozapine clinic for bipolar disorder and schizoaffective disorder. The study status is c…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]
The document reports on a clinical trial studying how ziprasidone affects glucose and lipid parameters in people with diabetes and in those …
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Completed clinical trial evaluating how atypical antipsychotics influence appetite and eating behavior in people with schizophrenia and schi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Phase 3]
Phase 3 trial comparing aripiprazole with standard of care on non-HDL cholesterol in adults with schizophrenia or bipolar I disorder and met…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update assessing cataract risk associated with quetiapine (Seroquel) and risperidone (Risperdal) in people with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [NA]
Clinical trial update about a follow-up study of intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder. …
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders [Phase 1]
A Phase 1 pharmacokinetic study evaluating risperidone and topiramate given alone and in combination in patients with bipolar disorder or sc…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone [Phase 1]
Phase 1 study evaluating the effects of immediate-release paliperidone on QT and QTc intervals in patients with schizophrenia or schizoaffec…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
A phase 3 randomized trial comparing a long-acting injectable risperidone formulation to olanzapine tablets in adults with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations [Phase 1]
Phase 1 pharmacokinetic study comparing paliperidone Extended-Release with risperidone Immediate-Release in adults with Schizophrenia or Sch…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Phase 1]
This Phase 1 safety and pharmacokinetic study evaluated the extended-release osmotic-release (ER OROS) formulation of paliperidone in pediat…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
The trial evaluated the safety and effectiveness of risperidone for acute psychosis in patients with schizophrenia or related disorders. The…
-
CLINICAL_TRIALS research · 2011-05-19Clinical Trial Update: PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders
Completed epidemiologic survey (PROFILe3) sponsored by Janssen-Cilag, evaluating patients with schizophrenia or schizoaffective disorders.